News & Analysis as of

Medical Marijuana United Kingdom

Medical Marijuana refers to the use of marijuana to treat or alleviate symptoms of certain illnesses. A growing number of states permit individuals to use marijuana on the recommendation of a physician. Despite... more +
Medical Marijuana refers to the use of marijuana to treat or alleviate symptoms of certain illnesses. A growing number of states permit individuals to use marijuana on the recommendation of a physician. Despite state laws to the contrary, Federal law still prohibits the use or possession of marijuana. The conflict between state and federal law on this issue has created interesting enforcement issues and significant legal hurdles for medical marijuana providers.  less -
Latham & Watkins LLP

Cannabis Rethink Sparks PE Interest

Latham & Watkins LLP on

The once shunned cannabis sector now offers attractive PE opportunities in many jurisdictions. In years gone by, the prospect of significant PE investment in the cannabis industry would have been unthinkable for many....more

Dechert LLP

UK Life Sciences and Healthcare Newsletter - June 2021: Medicinal Cannabis in the UK: Fund Structuring, Investment and Listing...

Dechert LLP on

The value of the global medicinal cannabis market is projected to reach US$62.7 billion by 2024, with over US$22 billion of that market generated by Europe and an estimated excess of £2 billion likely to be generated in the...more

World Law Group

2020 Global Cannabis Guide Chapters - England

World Law Group on

World Law Group member firms recently collaborated on a Global Cannabis Guide that provides a brief overview of laws and policies regarding the use of cannabis in various jurisdictions. It briefly outlines information on the...more

Sterne, Kessler, Goldstein & Fox P.L.L.C.

MarkIt to Market® - December 2020

[co-author: Joseph Diorio, Law Clerk] The December 2020 issue of Sterne Kessler's MarkIt to Market® newsletter discusses the implications of Brexit on .eu domain names owned by UK registrants, recent cannabis legislation,...more

Latham & Watkins LLP

Green Shoots for the Commercialisation of Cannabis-Based Medicinal Products in the UK?

Latham & Watkins LLP on

Recent legal and regulatory developments pave the way for an increased commercialisation opportunity in cannabis-based medicines, but complex rules require careful navigation. The National Institute for Health and Care...more

Skadden, Arps, Slate, Meagher & Flom LLP

Employment Flash - February 2020

This edition of Employment Flash looks at recent NLRB activity, including its decision (overruling an Obama-era decision) regarding confidentiality rules for employees during ongoing workplace investigations. We also discuss...more

A&O Shearman

NICE consults on draft guideline on prescribing medicinal cannabis

A&O Shearman on

On 8 August 2019, the National Institute for Health and Care Excellence (NICE) published a draft guideline on prescribing cannabis-based medicinal products (the Draft Guideline) for consultation. ...more

WilmerHale

Blurred Vision – Cannabis and Reporting

WilmerHale on

On 17 October, Canada legalised the recreational use of marijuana, following the passing of The Cannabis Act 2018 this summer. This marks a further step in the drug's deregulation in Canada, where its medical use has been...more

Stinson LLP

BankinBits First Quarter Recap

Stinson LLP on

The BankinBits blog, which discusses recent developments in the banking industry, has within the first quarter of 2014 addressed a diverse range of topics including banking services for the marijuana industry, the shuttering...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide